Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
That's bizarre This is all that comes up for me, Well glad others can see it.
CannaPharmaRx Announces CannaSyn Drug Discovery PlatformPress Release | 11/30/2015
CannaPharmaRx to Exhibit and Present at The MoneyShow in San Francisco, CaliforniaPress Release | 07/15/2015
CannaPharmaRx Closes Merger of Colorado SubsidiaryPress Release | 07/01/2015
CannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYCPress Release | 06/17/2015
CannaPharmaRx to Be a Featured Presenter at the Viridian Cannabis Investor ConferencePress Release | 06/11/2015
CannaPharmaRx to Present at 2015 Las Vegas MoneyShow May 11th to 14thPress Release | 05/07/2015
OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 5Announcement | 05/05/2015
CannaPharmaRx to Attend 2015 Armada Specialty Pharmacy Summit May 4th to 8thPress Release | 04/29/2015
CannaPharmaRx's Board of Directors Approves Plan of MergerPress Release | 04/24/2015
Don't bet against an abazaba375 stock.Trust me.You will lose.You have no idea who he is.
Some retailers who bought at 0.01’s to make small profits, or flipping.
Scroll down in that page, Man! Every news is listed there.
NEWS
CannaPharmaRx Acquiring Oklahoma Cannabis FacilityACCESSWIRE | 02/10/2022
CannaPharmaRx Stops Issuing Shares Under Previously Effective S-1ACCESSWIRE | 02/08/2022
CannaPharmaRx Enters into an Agreement for Supply of Genetics and Feed Stock to Accelerate Time to MarketACCESSWIRE | 01/25/2022
CannaPharmaRx Hires Key Personnel to Accelerate Output and Speed to Market for Cannabis ProductACCESSWIRE | 01/19/2022
CannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/YearACCESSWIRE | 01/06/2022
CannaPharmaRx completes 20-year operating lease for Alberta cannabis facilitySeeking Alpha | 01/06/2022
CannaPharmaRx completes 20-year operating lease for Alberta cannabis facilitySeeking Alpha | 01/06/2022
CannaPharmaRx completes 20-year operating lease for Alberta cannabis facilitySeeking Alpha | 01/06/2022
All news is listed.
I thought they stop to sell share as per 2/8 announcement. Who is selling?
Based on $40-$50 Million revenue/year, the market cap would go to $40-$50 million, or $3-$4/share pps. We'll see.
Yea but 11/30/2015 is last PR on OTC site
They have news on OTCMarket.com, here:
https://www.otcmarkets.com/stock/CPMD/news
Scroll down to 'News'. All news are listed there.
Very good.
This is not going anywhere
What's Confusing to me is, No News releases since 2015 show up on otcmarkets website, and Todays doesn't even show up on Etrade?? They need to get these PR's out to everyone.
Only 3mil market cap currently. $40-50mil per year annually would be very nice to boost market cap and pps.
I do not mind collecting down here and waiting for big gains. Np
Wow! This is Amazing! CPMD rolling forward hugely: $40 m - $50 m revenues per year, that is $0.3 -$0.4/share. This means that its pps should go to $2-$4 ranges.
O/S: 130 m, extremely low float!
We'll see.
CALGARY, AB / ACCESSWIRE / February 10, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities announced today that it has signed a Letter of Intent (LOI) to purchase an operating Cannabis facility located in Braman, Oklahoma.
The property consists of 35,000 square feet of cultivation capacity, with a planned, phased expansion to 65,000 square feet, by the end of 2022 and up to five harvests per year. The purchase will be completed via a secured note and will include the transfer of licenses. The transaction is expected to close prior to March 31, 2022.
The facility has ongoing growing and sales operations and should the deal be finalized CannapharmaRx will realize first harvest and sales from this property on closing. The estimated annual revenue is approximately $21 million. Between the current Cremona facility and this facility, the Company anticipates combined annual revenues of $40 - $50 million.
The Company, in addition to existing sales in Oklahoma, has received oral commitments for offtake agreements for both facilities and should finalize these deals prior to harvesting.
"The company continues to achieve significant milestones and should start to recognize significant revenue during early Q2. We continue to identify other areas for potential expansion and are confident in distribution on several continents by the middle of this year," commented Nick Colvin, CEO of CannapharmaRx.
About CannapharmaRx, Inc.
CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.
Safe Harbor Statement
Cautionary Note Regarding Forward-Looking Information or Statements
This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.
Contact Information:
Brokers and Analysts:
Chesapeake Group
(410) 825-3930
SOURCE: CannaPharmaRx
View source version on accesswire.com:
https://www.accesswire.com/688168/CannaPharmaRx-Acquiring-Oklahoma-Cannabis-Facility
Help rid your phone of malicious apps
Quote Lookup
Symbol Last Price Change % Change
CPMDCannaPharmaRX, Inc. 0.0272 +0.0050 +22.75%
TRENDING
1.
Chicken Wing Crunch Has Restaurants Scrambling Ahead of Super Bowl
2.
CANADA STOCKS-TSX gains on strong energy stocks; Canada Goose slumps
3.
Super Bowl 2022: Where to score free food, discounts and limited offerings
4.
UPDATE 1-California sues Tesla over allegations of racial discrimination
5.
No-fly list for unruly airplane passengers ‘incredibly important,’ flight attendant union boss says
$CPMD .025 break .0295 is up. NEWS acquisition, funding, 40-50mil revenue expected.
Only 3 mil market cap… I am wondering the math for 40-50mil annually.
Market Cap Market Cap
3,023,280
02/09/2022
Authorized Shares
300,000,000
02/04/2022
Outstanding Shares
136,183,783
02/04/2022
Restricted
33,909,814
02/04/2022
Unrestricted
102,273,969
02/04/2022
Held at DTC
100,084,922
02/04/2022
https://finance.yahoo.com/news/cannapharmarx-acquiring-oklahoma-cannabis-facility-134500429.html
https://finance.yahoo.com/news/cannapharmarx-stops-issuing-shares-under-140000796.html
Just printed 0.002725 Getting some attention this morning.
Nice dip.
""CPMD is in discussion with other companies regarding potential acquisitions"". --- When we get News on Acquisitions/Distribution Agreements CPMD could break 0.10 Easy, JMO GLTA
If CPMD can generate $30 million revenue per year it would go to dollars land. O/ S: only 130 m, very low.
Bring it down to .019 so I can get my full load and yes it is !
Revenue: $30 million per year, that’s Huge!
CannaPharmaRx Completes Long Term Lease for Cremona Production Facility Which Should Yield 6,000Kg ($30,000,000)/Year
https://finance.yahoo.com/news/cannapharmarx-completes-long-term-lease-144000465.html
This is going to get fun ..
Hmmm, this sounds good. This is the right thing for the management to do. It seems The investors like this. Now, will watch it closely.
CannaPharmaRx Stops Issuing Shares Under Previously Effective S-1
9:01 AM ET 2/8/22 | Dow Jones
CALGARY, AB / ACCESSWIRE / February 8, 2022 / CannaPharmaRx, Inc. (OTC PINK:CPMD), a future leader in ultramodern, highly efficient cannabis production facilities in Canada, announced today that it will no longer will be issuing shares under the previously effective S-1.
The S-1 included 135,000,000 registered shares and was filed on May 15, 2021. The S-1 went effective on June 11, 2021.
"While some shares have been issued and converted previously under the S-1 to advance the company to the stage it is currently at, it no longer makes sense to utilize the shares still available. We have received alternative funding, leased new facilities, and will be able to generate significant cash flow moving forward. We believe this is an important step for investors, as it limits any further dilution from these shares, " stated Nick Colvin, CEO of CannapharmaRx.
About CannapharmaRx, Inc.
CannapharmaRx is focused on the acquisition and development of state-of-the-art cannabis grow facilities in Canada. CPMD is in discussion with other companies regarding potential acquisitions. CannapharmaRx's business strategy is to become a leader in high quality and low-cost production of cannabis through the development, acquisition, and enhancement of existing facilities. CannapharmaRx is committed to operating high-quality facilities utilizing the latest technology in combined heat and power generation to ensure being a low-cost producer of cannabis.
Safe Harbor Statement
Cautionary Note Regarding Forward-Looking Information or Statements
This press release contains forward-looking information or statements. All statements that are or information which is not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations, or beliefs of future performance, are 'forward-looking information or statements.' Forward-looking information or statements can be identified by the use of words such as 'plans,' 'expects,' or 'does not expect,' 'is expected,' 'estimates,' 'intends,' 'anticipates,' or 'does not anticipate,' or 'believes,' or variations of such words and phrases or statements that certain actions, events or results 'may,' 'could,' 'would,' 'might' or 'will' be taken, occur or be achieved. With respect to forward-looking information and statements contained herein, Management of CannapharmaRx has made numerous assumptions, including, among other things, assumptions about general business and economic conditions. Such forward-looking statements are based on assumptions and involve known and unknown risks, uncertainties, and other factors that may cause actual results, events, or developments to be materially different from any future results, events, or developments expressed or implied by such forward-looking information or statements. Readers are cautioned not to place undue reliance on such forward-looking information or statements. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking information or statements. CannapharmaRx assumes no obligation to update any forward-looking information or statements, even if new information becomes available as a result of future events, new information, or for any other reason except as required by law.
Contact Information:
Brokers and Analysts:
Chesapeake Group
(410) 825-3930
SOURCE: CannaPharmaRx, Inc.
View source version on accesswire.com:
https://www.accesswire.com/687683/CannaPharmaRx-Stops-Issuing-Shares-Under-Previously-Effective-S-1
> Dow Jones Newswires
February 08, 2022 09:01 ET (14:01 GMT)
CPMD, diluting 130 Million new shares currently. Here:
Diluted 20 Million new shares in Dec. O/S increased to 125 M from 105 M in Dec. 2021.
https://www.otcmarkets.com/stock/CPMD/security
Still 115 Million new shares dumping to the markets: total: 135 Million new shares are issued:
https://www.otcmarkets.com/filing/html?id=14955763&guid=nTSwkW68_wPHOth
The big question is that nobody is buying this Garbage .
Good luck :) any big news I’ll stay also
.10 sounds reasonable to me..If we break this 128 day simple moving average I’ll be holding till .2 plus
Way under value … imho .10 maybe
A.S. Only 300,000,000 Take logic into account. If they issued all that’s left of the A.S. and even if they didn’t purchase another business or facility then our market cap at today’s price would still be 400-500% under value based on $30,000,000 annual revenue from the deal on the table. Next step, seeing sells contracts being made will only solidify the potential here. This is my opinion. Do your research
News is out on CPMD
https://t.co/nbNZYLTOi7
CPMD, Diluted another 10 Million shares since Jan. 06, still 100 Million shares for diluting on the way. LOL.
$30m Rev / 136,183,783 OS = .22 pps
$30m Rev x 20 years / (136,183,783 OS) = $4.40 pps
CPMD...024...seller left the box...lets see if that sticks here...:partying_face:
.02 x .023 hopefully that was the bottom and it can now regain support here in the low .02 range ahead of another push back up to .03+ area.
LOL. There are no shorts here bud. Just newly issued shares by the company that are finding their way into the tradeable float. O/S is now 136M, up from 125M at the start of the year. It's dilution, plain and simple. Still a great share structure here but going to need to churn through this overhang for a bit before we can start moving back up to .03+ area.
Interesting info posted on Stocktwits. Looks like float may be locked and shorts are in trouble.
Needs to hold .02 this week. Seller still dumping shares unfortunately so could dip into .01s
Outstanding Shares
134,073,168
01/07/2022
Restricted
33,909,814
01/07/2022
Unrestricted
100,163,354
01/07/2022
I see an increase as expected. This will eventually churn through what remains from the S1 and see a big move to much higher levels.
Nice ddamanda. 200day low and 43 fact.
That news was quite good. Short sellers jumped in here. It’s okay. Some will miss the churn and climb like last year 52 week high was .68.
Lol no rs coming here. SS already very solid.
Market Cap Market Cap
3,405,640
01/06/2022
Authorized Shares
300,000,000
12/31/2021
Outstanding Shares
126,134,810
12/31/2021
Restricted
33,909,814
12/31/2021
Unrestricted
92,224,996
12/31/2021
Held at DTC
90,035,949
12/31/2021
#DDAmanda Chart on: $CPMD
You can find these before they run.
What the Fact (Factor) Column is:
The Factor is a proprietary indicator used for scanning in #DDAmanda.
It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).
SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.
That's significant, and many times indicates that a run in the stock is coming.
Would ideally like to see this hold .02 as the bottom and push back upwards next week. Let’s see if the volume holds up.
Nice grab...imo...
Great loading opportunity
Followers
|
32
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
746
|
Created
|
04/23/07
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |